A review of the safety of selective serotonin reuptake inhibitors during pregnancy
Human Psychopharmacology Clinical and ExperimentalPublished 1 July 1999
D. Goldstein, Karen Sundell
Citations19
SJR quartileQ3
SJR score0.51
SNIP0.59
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The substantial clinical experience with fluoxetine‐exposed pregnancies and the preliminary data regarding other SSRIs is reassuring when considering depression treatment for women of child‐bearing potential.
Abstract
Antidepressant treatment may be desirable or necessary during pregnancy; however, the benefit of treatment must balance the benefits to the mother with any risk to the developing fetus. In order to make educated, patient-specific, benefit-to-risk assessments, an understanding of possible risks associated with in-utero antidepressant exposure is important. We reviewed all published cohort-controlled studies (n=4) and prospective surveys (n=5) regarding SSRI use in pregnancy. Outcomes from over 1000 fluoxetine-exposed pregnancies, more than for any other antidepressant, indicate that first trimester fluoxetine exposure does not statistically significantly increase risk for spontaneous abortion or major malformation. Outcomes from nearly 300 pregnancies exposed to another SSRI (sertraline, paroxetine, or fluvoxamine) suggest the same conclusion. Following in-utero SSRI exposure, birthweight, rates of prematurity, and postnatal complications appear similar to control values. Preschool age children exposed to fluoxetine in-utero show no significant differences from controls in global IQ, language, or behavior; such long-term data are not available for other SSRIs. The substantial clinical experience with fluoxetine-exposed pregnancies and the preliminary data regarding other SSRIs is reassuring when considering depression treatment for women of child-bearing potential. Copyright © 1999 John Wiley & Sons, Ltd.
Keywords
PsychologySocial SciencesMedicine
Archives of General PsychiatryLifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States
12,491 Citations1994Ronald C. Kessler
The prevalence of psychiatric disorders is greater than previously thought to be the case, and morbidity is more highly concentrated than previously recognized in roughly one sixth of the population who have a history of three or more comorbid disorders.
American Journal of PsychiatryThe prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey
1,480 Citations1994Dan G. Blazer, Ronald C. Kessler +2 more
A greater burden of major depression in community-dwelling persons than has been estimated from previous community samples is suggested and the risk factor profile showed significant differences between persons with pure and combined major depression.
Archives of General PsychiatryThree-Year Outcomes for Maintenance Therapies in Recurrent Depression
1,309 Citations1990David J. Kupfer
It is concluded that active imipramine treatment is an effective means of preventing recurrence beyond 3 years and that patients with previous episodes less than 2 1/2 years apart, therefore, merit continued prophylaxis for at least 5 years.
New England Journal of MedicineBirth Outcomes in Pregnant Women Taking Fluoxetine
738 Citations1996Christina Chambers, Kathleen A. Johnson +3 more
Women who take fluoxetine during pregnancy do not have an increased risk of spontaneous pregnancy loss or major fetal anomalies, but women who take the drug in the third trimester are at increased risk for perinatal complications.
New England Journal of MedicineNeurodevelopment of Children Exposed in Utero to Antidepressant Drugs
578 Citations1997Irena Nulman, Joanne Rovet +6 more
American Journal of Public HealthAdvances in psychiatric epidemiology: rates and risks for major depression.
442 Citations1987Myrna M. Weissman
Results from a recently completed epidemiologic survey of psychiatric disorders in five urban communities in the United States and from several large-scale family genetic studies suggest that major depression is a highly prevalent disorder.
JAMAPregnancy Outcome Following Maternal Use of the New Selective Serotonin Reuptake Inhibitors
429 Citations1998Nathalie A. Kulin, Anne Pastuszak +11 more
The new SSRIs, fluvoxamine, paroxetine, and sertraline, do not appear to increase the teratogenic risk when used in their recommended doses.
The Journal of PediatricsCongenital anomalies in the newborninfant, including minor variations
426 Citations1964Philip M. Marden, David W. Smith +1 more
The detection of multiple minor anomalies may be of value in alerting the physician to the existence of an obscure major abnormality or the recognition of a specific multiple anomaly syndrome.
Journal of Clinical EpidemiologySelf-reported depression and negative pregnancy outcomes
405 Citations1992Robert A. Steer, Theresa O. Scholl +2 more
There was no relationship of BDI scores with pregnancy outcome in the adolescents or adults, but among the adult gravidas the risk of a poor outcome rose 5-7% for each point the BDI total score increased, and physiological mechanisms associated with symptoms of depression might contribute to an increased risk of poor outcomes.
Archives of General PsychiatryFive-Year Outcome for Maintenance Therapies in Recurrent Depression
371 Citations1992David J. Kupfer
JAMAPregnancy Outcome Following First-Trimester Exposure to Fluoxetine (Prozac)
371 Citations1993Anne Pastuszak
New England Journal of MedicineSympathetic Cardioneuropathy in Dysautonomias
324 Citations1997David S. Goldstein, Courtney Holmes +3 more
A new clinical pathophysiologic classification of dysautonomias is supported, based on the occurrence of sympathetic neurocirculatory failure, signs of central neurodegeneration, and responsiveness to levodopa-carbidopa.
PEDIATRICSTHE INCIDENCE OF CONGENITAL MALFORMATIONS: A STUDY OF 5,964 PREGNANCIES
312 Citations1954R. McIntosh, Katharine Merritt +3 more
A prospective study of the outcome of 5,964 pregnancies, with special emphasis on the relationship of factors in fetal environment to the incidence of abortions, stillbirths, neonatal mortality and congenital malformations, finds thatMalformations of musculo-skeletal system and skin were more frequent than mal Formations of other systems.
Epidemiologic ReviewsMaternal Depressive Symptoms and the Risk of Poor Pregnancy Outcome
275 Citations1995Suezanne Tangerose Orr, C. Arden Miller
Reproductive ToxicologyThe outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS)
203 Citations1996Patricia R. McElhatton, Hanneke Garbis +10 more
No causal relationship could be established between in utero exposure to antidepressants and adverse pregnancy outcome and the most striking feature of the pregnancy outcomes is that 97% of live-born babies were morphologically normal.
BJOG An International Journal of Obstetrics & GynaecologyThe effect of anxiety and depression during pregnancy on obstetric complications
157 Citations1993Michael R. Perkin, John M. Bland +2 more
Obstetrics and GynecologyEffects of First-Trimester Fluoxetine Exposure on the Newborn
138 Citations1997D. Goldstein
It is unlikely that maternal fluoxetine use during the first trimester of pregnancy results in increased risk of fetal malformations, based on comparison with historic reports of newborn surveys.
Journal of Clinical PsychopharmacologyEffects of Third Trimester Fluoxetine Exposure on the Newborn
115 Citations1995D. Goldstein
It is unlikely that maternal fluoxetine use during the third trimester results in significant postnatal complications, and reported rates from the National Hospital Discharge Survey are likely to be low.
New England Journal of MedicineMaternal Health and Congenital Defect
105 Citations1958Alison D. McDonald
Investigations of the influence of maternal health during the first few months of pregnancy have been unsatisfactory when made after the birth of the child; an accurate history of events six to nine months earlier is difficult to obtain, and bias is introduced by the mother's knowledge of the outcome.
New England Journal of MedicineTreating Depression in Pregnancy
48 Citations1996Elisabeth Robert
Pregnancy is frequently thought of as a time of emotional well-being for women, but it does not protect them from mood instability, and is a risk factor for depressive illness.
PsychosomaticsPsychotropics during pregnancy and lactation: A review
43 Citations1985Joseph R. Calabrese, A. Dale Gulledge
By relating the data available to the urgency of the patient's need for psychotropic treatment, the physician can strive for an optimal benefit-to-risk decision in what at present is one of the most unclear and difficult areas of psychiatric drug prescription.
Neurologic ClinicsCourse of Psychiatric Disorders in Pregnancy
40 Citations1994Lori L. Altshuler, Martin P. Szuba
Large epidemiologic follow-up studies of children exposed to medication in utero may help clarify questions relating to behavioral changes and thus help guide clinical decisions.
PubMedCourse of psychiatric disorders in pregnancy. Dilemmas in pharmacologic management.
37 Citations1994Lori L. Altshuler, Martin P. Szuba
New England Journal of MedicineAuditing the Medicare-Billing Practices of Teaching Physicians — Welcome Accountability, Unfair Approach
28 Citations1997Jordan J. Cohen, Robert M. Dickler
Medicine has always embraced the concept of public accountability but until now has not had to face its reality.
PubMed[Follow-up of 151 pregnant women exposed to antidepressant treatment (MAOI excluded) during organogenesis].
16 Citations1995P. Brunel, Thierry Vial +3 more
The study's ability to detect an overall increase in the risk of malformations is too low and limited the extent of the conclusion, but the results are in agreement with the literature data as no important increased in major birth defect was observed.
PubMedBirth control failure among patients with unwanted pregnancies: 1982-1984.
12 Citations1986Sophocles Am, Brozovich Em
Overall, fewer than one quarter of unwanted pregnancies among the predominantly white, middle-class population studied resulted from failure to obtain contraception, and only 19 percent represented technical failure despite correct and consistent use.
Clinical Pharmacology & TherapeuticsNeurodevelopment of children exposed to fluoxetine(FL) in utero: A prospective longitudinal study.
8 Citations1996Irena Nulman, Joanne Rovet +3 more
Primary Care Update for OB/GYNSDepression and pregnancy: Use of selective serotonin reuptake inhibitors in pregnancy
7 Citations1998Peter J. McConnell, Kathy Linn +1 more
These findings are consistent with previous reports indicating no increase in major malformation rate and a possible slight association with decreased birth weight with longer duration of exposure, but additional data are needed.